15.76
price up icon5.14%   0.77
after-market 시간 외 거래: 15.80 0.04 +0.25%
loading

왜 Avadel Pharmaceuticals Plc (AVDL) 주가가 하락하고 있습니까?

2025-06-12 거래 세션 동안 Avadel Pharmaceuticals Plc(AVDL) 주식이 5.56% 하락한 것을 확인했습니다. 이는 정상적인 변동성이나 다양한 내부 및 외부 요인에 의한 것일 수 있지만, 상황을 적극적으로 모니터링하고 있으며 최대한 빨리 적시에 업데이트를 제공하도록 하겠습니다!
2023-06-23:

AVDL's stock fell 11.41% following Jazz Pharmaceuticals' lawsuit against the FDA for violating the orphan drug exclusivity of Xywav by approving Avadel Pharmaceuticals' Lumryz, which is an extended-release reformulation of its high sodium oxybate product Xyrem for narcolepsy.

https://www.benzinga.com/general/biotech/23/06/32982101/jazz-pharmaceuticals-sues-fda-over-approval-of-rival-product-calls-it-unlawful

$29.94
price up icon 3.53%
$18.43
price up icon 5.50%
drug_manufacturers_specialty_generic RDY
$14.34
price up icon 1.34%
$10.50
price up icon 1.65%
$144.10
price up icon 2.64%
$400.52
price up icon 5.27%
자본화:     |  볼륨(24시간):